The Preclinical Foundation: How Obesity Models Drive Therapeutic Breakthroughs
The global escalation of metabolic disorders has transformed obesity from a secondary health concern into a primary clinical challenge, necessitating...
Read moreThe global escalation of metabolic disorders has transformed obesity from a secondary health concern into a primary clinical challenge, necessitating...
Read moreThe Hidden Workhorse of Drug Discovery Behind every breakthrough in obesity drug development lies an enzyme substrate. While GLP-1 agonists...
Read more






